Bioinformatic analysis of epidemiological and pathological data

Pathology and Epidemiology of Cancer

Volumn , Issue , 2016, Pages 91-104

  Tyekucheva, Svitlana ^a   Parmigiani, Giovanni ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026689034     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-35153-7_8     Document Type: Chapter

References (57)

1. The Cancer Genome Atlas. 2015. Available from http://cancergenome.nih.gov/abouttcga/overview. Cited July 2015.
2. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004 Dec 30; 351(27): 2817-26. PubMed PMID: 15591335.
3. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006 Aug 10; 24(23): 3726-34. PubMed PMID: 16720680.
4. The TAILORx Breast Cancer Trial. 2015. Available from http://www.cancer.gov/types/breast/research/tailorx. Cited Dec 2015.
5. The RxPONDER Breast Cancer Trial. 2015. Available from http://www.cancer.gov/about-cancer/treatment/clinical-trials/search/view?cdrid=692475. Cited Dec 2015.
6. Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol. 2007; 25: 4350-7. J Clin Oncol. 2010 Dec 10; 28(35): 5229. PubMed PMID: 21148129.
7. Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol. 2012 Feb 20; 30(6): 678. PubMed PMID: 22451975.
8. Baggerly K, Coombes K. Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann Appl Stat. 2009; 26(7): 1186-7.
9. Baron AE, Bandeen-Roche K, Berry DA, Bryan J, Carey VJ, Chaloner K, et al. Letter to Harold Varmus: concerns about prediction models used in duke clinical trials. MD: Bethesda; 2010.
10. Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, et al. Retraction-validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol. 2011 Feb;12(2):116. PubMed PMID: 21277543.
11. Potti A, Dressman HK, Bild A, Chan G, Sayer R, Cragun J, et al. Retraction: genomic signatures to guide the use of chemotherapeutics. Nature Med. 2011; 17(1): 135.
12. Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, et al. Retraction: a genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med. 2011; 364(12): 1176.
13. Committee on the review of omics-based tests for predicting patient outcomes in clinical trials. In: Micheel CM, Nass SJ, Omenn GS, editors. Washington, DC; 2012.
14. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004; 5(10): R80. PubMed PMID: 15461798. Pubmed Central PMCID: 545600.
15. Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet. 2010 Oct;11(10):733-9. PubMed PMID: 20838408. Pubmed Central PMCID: 3880143.
16. Parker HS, Leek JT. The practical effect of batch on genomic prediction. Stat Appl Genet Mol Biol. 2012; 11(3): Article 10. PubMed PMID: 22611599. Pubmed Central PMCID: 3760371.
17. Baggerly KA, Coombes KR, Neeley ES. Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer. J Clin Oncol. 2008 Mar 1; 26(7): 1186-7; Author reply 7-8. PubMed PMID: 18309960.
18. van Dijk EL, Jaszczyszyn Y, Thermes C. Library preparation methods for next-generation sequencing: tone down the bias. Exp Cell Res. 2014 Mar 10; 322(1): 12-20. PubMed PMID: 24440557.
19. Johnson EW, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007; 8(1): 118-27.
20. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012 Mar 15; 28(6): 882-3. PubMed PMID: 22257669. Pubmed Central PMCID: 3307112.
21. Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 2007 Sept;3(9):1724-35. PubMed PMID: 17907809. Pubmed Central PMCID: 1994707.
22. Parker HS, Leek JT, Favorov AV, Considine M, Xia X, Chavan S, et al. Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction. Bioinformatics. 2014 Oct;30(19):2757-63. PubMed PMID: 24907368. Pubmed Central PMCID: 4173013.
23. Gene Expression Omnibus. 2015. Available from http://www.ncbi.nlm.nih.gov/geo/. Cited July 2015.
24. Array Express. 2015. Available from http://www.ebi.ac.uk/arrayexpress/. Cited July 2015.
25. Sequence Reads Archive. 2015. Available from http://www.ncbi.nlm.nih.gov/sra/. Cited July 2015.
26. Waldron L, Riester M. doppelgangR: identify possibly duplicate samples in a list of ExpressionSets (July 2015). Available from https://github.com/lwaldron/doppelgangR.
27. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003 Apr;4(2):249-64. PubMed PMID: 12925520.
28. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA. 2001 Jan 2; 98(1): 31-6. PubMed PMID: 11134512. Pubmed Central PMCID: 14539.
29. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009 May 1; 25(9): 1105-11. PubMed PMID: 19289445. Pubmed Central PMCID: 2672628.
30. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013; 14(4): R36. PubMed PMID: 23618408. Pubmed Central PMCID: 4053844.
31. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-Seq aligner. Bioinformatics. 2013 Jan 1; 29(1): 15-21. PubMed PMID: 23104886. Pubmed Central PMCID: 3530905.
32. Huang S, Zhang J, Li R, Zhang W, He Z, Lam TW, et al. SOAPsplice: genome-wide ab initio detection of splice junctions from RNA-Seq data. Front Genet. 2011; 2: 46. PubMed PMID: 22303342. Pubmed Central PMCID: 3268599.
33. Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015 Jan 15; 31(2): 166-9. PubMed PMID: 25260700. Pubmed Central PMCID: 4287950.
34. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009 Aug 15; 25(16): 2078-9. PubMed PMID: 19505943. Pubmed Central PMCID: 2723002.
35. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011; 12: 323. PubMed PMID: 21816040. Pubmed Central PMCID: 3163565.
36. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010 May; 28(5): 511-5. PubMed PMID: 20436464. Pubmed Central PMCID: 3146043.
37. Roberts A, Pimentel H, Trapnell C, Pachter L. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics. 2011 Sep 1; 27(17): 2325-9. PubMed PMID: 21697122.
38. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008 July; 5(7): 621-8. PubMed PMID: 18516045.
39. Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010; 11: 94. PubMed PMID: 20167110. Pubmed Central PMCID: 2838869.
40. Risso D, Schwartz K, Sherlock G, Dudoit S. GC-content normalization for RNA-Seq data. BMC Bioinformatics. 2011; 12: 480. PubMed PMID: 22177264. Pubmed Central PMCID: 3315510.
41. Hansen KD, Irizarry RA, Wu Z. Removing technical variability in RNA-Seq data using conditional quantile normalization. Biostatistics. 2012 Apr; 13(2): 204-16. PubMed PMID: 22285995. Pubmed Central PMCID: 3297825.
42. Waldron L, Ogino S, Hoshida Y, Shima K, McCart Reed AE, Simpson PT, et al. Expression profiling of archival tumors for long-term health studies. Clin Cancer Res. 2012 Nov 15; 18(22): 6136-46. PubMed PMID: 23136189. Pubmed Central PMCID: 3500412.
43. Tyekucheva S, Martin NE, Stack EC, Wei W, Vathipadiekal V, Waldron L, et al. Comparing platforms for messenger RNA expression profiling of archival formalin-fixed, Paraffin-embedded tissues. J Mol Diagn. 2015 July; 17(4): 374-81. PubMed PMID: 25937617. Pubmed Central PMCID: 4483460.
44. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-Sequencing and microarray studies. Nucleic Acids Res. 2015 Apr 20; 43(7): e47. PubMed PMID: 25605792. Pubmed Central PMCID: 4402510.
45. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3: Article3. PubMed PMID: 16646809.
46. Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-Seq read counts. Genome Biol. 2014; 15(2): R29. PubMed PMID: 24485249. Pubmed Central PMCID: 4053721.
47. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol. 2014; 15(12): 550. PubMed PMID: 25516281. Pubmed Central PMCID: 4302049.
48. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995; 57(1): 289-300.
49. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001; 29(4): 1165-88.
50. Storey JD. A direct approach to false discovery rates. J Roy Stat Soc B. 2002; 64(3): 479-98.
51. Efron B, Tibshirani R. Empirical Bayes methods and false discovery rates for microarrays. Genet Epidemiol. 2002 Jun; 23(1): 70-86. PubMed PMID: 12112249.
52. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006 Aug; 38(8): 904-9. PubMed PMID: 16862161.
53. Braun R, Cope L, Parmigiani G. Identifying differential correlation in gene/pathway combinations. BMC Bioinformatics. 2008; 9: 488. PubMed PMID: 19017408. Pubmed Central PMCID: 2613418.
54. Ackermann M, Strimmer K. A general modular framework for gene set enrichment analysis. BMC Bioinformatics. 2009; 10: 47. PubMed PMID: 19192285. Pubmed Central PMCID: 2661051.
55. Broad Institute. Molecular signatures database. Available from http://www.broadinstitute.org/gsea/msigdb/index.jsp. July 2015.
56. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005 Oct 25; 102(43): 15545-50. PubMed PMID: 16199517. Pubmed Central PMCID: 1239896.
57. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009 Nov 5; 462(7269): 108-12. PubMed PMID: 19847166. Pubmed Central PMCID: 2783335.